6th Alpine Meeting: Enhancing the Efficacy of Cancer Drugs – the Need for a Paradigma Shift
Innsbruck, Austria – 4 to 6 October 2011
5th Alpine Meeting
Innsbruck, Austria – 3 to 5 March 2010
London, United Kingdom – 5 & 6 December 2011
BDA Working Group Meeting – HTA Meeting 2011: Actual developments in European Regulatory and HTA Management – What does this mean for oncology in Europe?
Bonn, Germany – 9 March 2011
Combination New Molecullar Entities in Oncology: Opportunities and Challenges
Brussels, Belgium – 7 December 2010
10th International Symposium Biological Therapy of Cancer: from Disease to Targeted Therapy (BTOC 10)
Munich, Germany – 8 to 10 September 2010
BDA Workshop – Oncology Biomarker Based Drug Development
Brussels, Belgium – 9 February 2010
BDA ISBTc/FDA Taskforce Meeting
Washington, DC, US – 29 October 2009
BDA Meeting – Critical Success Factors for New Oncology Products
Brussels, Belgium – 10 September 2009
BDA Industry Consutative Meeting
Vienna, Austria – 3 April 2009
BDA Meeting – Market & Patient Access to New Oncology Products in Europe
Brussels, Belgium – 29 November 2007